Springer Reviews on New Drug Targets in Age-Related Disorders

As the global population ages, the demand for effective treatments for age-related conditions continues to grow. This volume from the Advances in Experimental Medicine and Biology series, number 1260, addresses the social, economic, and health challenges posed by an increasing number of individuals in advanced age categories. This book examines the rising probability of developing various age-related disorders, including type II diabetes mellitus, cardiovascular disorders, sarcopenia, and neurodegenerative conditions. It highlights the urgent need for new therapeutic approaches to slow or decrease the impact of these diseases. Readers will explore how advances in -omic technologies have transformed the field. The text covers significant developments in genomics, transcriptomics, proteomics, and metabolomics, providing a foundation for understanding modern research in drug target identification. This is an essential resource for those studying the biological mechanisms of aging and the development of next-generation medical interventions.